The PE Ratio as of November 2024 (TTM) for Lantheus Holdings, Inc. (LNTH) is 15.04

According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 15.04. This represents a change of 9.30% compared to the average of 13.76 of the last 4 quarters.

Lantheus Holdings, Inc. (LNTH) Historical PE Ratio (quarterly & annually)

How has LNTH PE Ratio performed in the past?

The mean historical PE Ratio of Lantheus Holdings, Inc. over the last ten years is 7.28. The current 15.04 PE Ratio has changed 20.56% with respect to the historical average. Over the past ten years (40 quarters), LNTH's PE Ratio was at its highest in in the December 2014 quarter at 197.00. The PE Ratio was at its lowest in in the March 2023 quarter at -498.16.

Lantheus Holdings, Inc. (LNTH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lantheus Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lantheus Holdings, Inc. (LNTH) Average PE Ratio

How has LNTH PE Ratio performed in the past?

The current PE Ratio of Lantheus Holdings, Inc. (LNTH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Lantheus Holdings, Inc. (LNTH) PE Ratio vs. Peers

How is LNTH’s PE Ratio compared to its peers?

Lantheus Holdings, Inc.’s PE Ratio is less than Neurocrine Biosciences, Inc. (32.92), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Ironwood Pharmaceuticals, Inc. (21.99), greater than Alkermes plc (14.10), greater than Avadel Pharmaceuticals plc (-15.47), less than ANI Pharmaceuticals, Inc. (0), greater than Dr. Reddy's Laboratories Limited (-155.73), greater than Collegium Pharmaceutical, Inc. (3.74), greater than Pacira BioSciences, Inc. (10.91), greater than Alvotech (-8.92), greater than Catalent, Inc. (-7.17), greater than Amphastar Pharmaceuticals, Inc. (-26.87), greater than Journey Medical Corporation (14.01), greater than Aquestive Therapeutics, Inc. (-6.01), greater than Dynavax Technologies Corporation (-11.80), less than null (79.53),

Build a custom stock screener for Lantheus Holdings, Inc. (LNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantheus Holdings, Inc. (LNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.